Press Room Video Gallery Proactive Investors interview Cameron Reynolds at the MicroCap Conference, NYC, October 2018 Proactive Investors interview Cameron Reynolds at the MicroCap Conference, NYC, October 2018 Play video Video gallery VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test Play video Volition Announces Proof of Concept Data in Lymphoma and Leukemia Play video Proactive Interview with Cameron Reynolds, President & CEO Play video Third Quarter 2019 Results & Business Update - an interview with Cameron Reynolds Play video Signing Ceremony with interviews from members of the Volition and Texas A&M Teams Play video Proactive Investor Interview Quarter Two Earnings Update Play video An interview with Cameron Reynolds regarding Quarter Two 2019 Earnings Update Play video Volition forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Play video First Quarter 2019 Earnings Interview with Cameron Reynolds Play video